National and Kapodistrian University of Athens
Η επίδραση της χορήγησης βιταμίνης D και της 1,25 διϋδρόξυ-βιταμίνης D3 στα επίπεδα πλάσματος του ινοβλαστικού αυξητικού παράγοντα 23 (FGF-23) σε ασθενείς με ανεπάρκεια βιταμίνης D
Abstract
dc:descriptionContext: FGF-23 is a phosphaturic protein that acts in the renal proximal tubule resulting in inhibitionof phosphate reabsorption due to suppression of expression of NaPi-IIa/c cotransporters andsuppression of calcitriol synthesis. FGF-23 plays a crucial role in vitamin D metabolism by inhibitingcalcitriol synthesis. In turn, calcitriol stimulates FGF-23 production by osteocytes and matureosteoblasts.Objective: Proposed positive regulators of FGF-23 production by osteocytes include phosphate,calcitriol and PTH at least in animal studies. However definite data in humans are lacking. We aimed toinvestigate the effect of vitamin D replacement therapy or calcitriol co-administration on FGF-23serum concentrations in vitamin D deficient women.Design and methods: Twenty-eight pre and postmenopausal women with vitamin D deficiencyrandomized in two groups (Group I ; n=14, mean age 56±8.9 years), (Group II ; n=14, mean age55±3.9 years) and twenty-seven healthy subjects (controls group; mean age 55±7.6 years) comparablefor age and anthropometric measures, participated. Samples were taken for serum FGF-23, calcium,phosphate, calciotropic hormones and bone markers. The groups with vitamin D deficiency were reevaluated,one and three months later, after calcitriol 0.5 μg bid or cholecalciferol 800 iu qd.Results: At baseline FGF-23 did not differ between vitamin D deficiency and control group. In vitaminD deficiency group there was found a significant positive correlation between serum FGF-23, calciumserum (p=0.046), calcium urine 2h in fasting state (p=0.034) and osteocalcin concentrations (p=0.019)before initiating treatment. At one month following calcitriol administration there was significantdecrease of FGF-23 levels (p=0.011). No significant change of FGF-23 was observed in thecholecalciferol group. Three months after initiating treatment FGF-23 levels increased in calcitriolgroup, while it did not change in the cholecalciferol group. In calcitriol group FGF-23 levels increasedsignificantly (p=0.002) and was positively correlated with decreased 1,25(OH)2D levels (p=0.003) andincrease renal phosphate excretion 24h (p=0.002).Conclusion: : 1,25(OH)2D is a major regulator of the expression of FGF-23 in humans. In conditionsof vitamin D deficiency, calcitriol seems to decrease FGF-23 leading to conservation of the calcium –phosphorus product.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Georgoulas, Thomas
- Γεωργούλας, Θωμάς
Subjects
dc:subject × 19- Ινοβλαστικός αυξητικός παράγοντας 23
- Ανεπάρκεια βιταμίνης D
- Καλσιτριόλη
- Ασβέστιο
- Φώσφορος
- Fibroblast growth factor 23
- Vitamin D deficiency
- Calcitriol
- Phosphate
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Άλλες Ιατρικές Επιστήμες
- Γεωπονικές Επιστήμες και Κτηνιατρική
- Γεωπονική Βιοτεχνολογία
- Medical and Health Sciences
- Clinical Medicine
- Other Medical Sciences
- Agricultural and Veterinary Sciences
- Agricultural Biotechnology
Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42374